Lucas A. Horn

2.5k total citations
27 papers, 1.9k citations indexed

About

Lucas A. Horn is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Lucas A. Horn has authored 27 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 18 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Lucas A. Horn's work include Cancer Immunotherapy and Biomarkers (13 papers), Immunotherapy and Immune Responses (10 papers) and Immune Cell Function and Interaction (9 papers). Lucas A. Horn is often cited by papers focused on Cancer Immunotherapy and Biomarkers (13 papers), Immunotherapy and Immune Responses (10 papers) and Immune Cell Function and Interaction (9 papers). Lucas A. Horn collaborates with scholars based in United States, Czechia and Germany. Lucas A. Horn's co-authors include Suzanne Ostrand‐Rosenberg, Claudia Palena, Kristen Fousek, Katherine H. Parker, Samuel Haile, Jeffrey Schlom, Pratima Sinha, Dean Y. Maeda, Virginia K. Clements and John A. Zebala and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and Cancer Research.

In The Last Decade

Lucas A. Horn

27 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lucas A. Horn United States 20 1.2k 1.0k 462 216 163 27 1.9k
Tomasz Ahrends United States 11 1.3k 1.1× 1.1k 1.1× 585 1.3× 217 1.0× 211 1.3× 15 2.1k
Kim Vrijland Netherlands 12 1.4k 1.2× 1.1k 1.1× 542 1.2× 187 0.9× 253 1.6× 17 2.1k
Armelle Prévost‐Blondel France 27 1.8k 1.6× 1.4k 1.4× 672 1.5× 160 0.7× 253 1.6× 46 2.7k
Elisa Peranzoni France 18 2.1k 1.8× 1.3k 1.3× 587 1.3× 196 0.9× 242 1.5× 29 2.9k
Elise Alspach United States 14 856 0.7× 679 0.7× 632 1.4× 147 0.7× 210 1.3× 19 1.7k
Eva Van Overmeire Belgium 16 1.3k 1.1× 767 0.8× 582 1.3× 108 0.5× 233 1.4× 20 1.9k
Helena Harlin United States 16 1.6k 1.4× 1.3k 1.3× 742 1.6× 114 0.5× 185 1.1× 25 2.4k
Alessandra Mancino Italy 13 1.1k 0.9× 718 0.7× 562 1.2× 108 0.5× 312 1.9× 17 1.9k
Beom K. Choi South Korea 29 1.9k 1.6× 882 0.9× 460 1.0× 96 0.4× 160 1.0× 70 2.6k
Tomohisa Baba Japan 26 865 0.7× 756 0.8× 597 1.3× 111 0.5× 180 1.1× 54 1.8k

Countries citing papers authored by Lucas A. Horn

Since Specialization
Citations

This map shows the geographic impact of Lucas A. Horn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucas A. Horn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucas A. Horn more than expected).

Fields of papers citing papers by Lucas A. Horn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucas A. Horn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucas A. Horn. The network helps show where Lucas A. Horn may publish in the future.

Co-authorship network of co-authors of Lucas A. Horn

This figure shows the co-authorship network connecting the top 25 collaborators of Lucas A. Horn. A scholar is included among the top collaborators of Lucas A. Horn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucas A. Horn. Lucas A. Horn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Horn, Lucas A., Hanne Lind, Kristen Fousek, et al.. (2024). Inhibition of the chemokine receptors CXCR1 and CXCR2 synergizes with docetaxel for effective tumor control and remodeling of the immune microenvironment of HPV-negative head and neck cancer models. Journal of Experimental & Clinical Cancer Research. 43(1). 318–318. 4 indexed citations
2.
Minnar, Christine M., Paul L. Chariou, Lucas A. Horn, et al.. (2022). Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies. Journal for ImmunoTherapy of Cancer. 10(6). e004561–e004561. 34 indexed citations
3.
Fousek, Kristen, Lucas A. Horn, Haiyan Qin, et al.. (2022). An Interleukin-15 Superagonist Enables Antitumor Efficacy of Natural Killer Cells Against All Molecular Variants of SCLC. Journal of Thoracic Oncology. 18(3). 350–368. 20 indexed citations
4.
Horn, Lucas A., Kristen Fousek, & Claudia Palena. (2020). Tumor Plasticity and Resistance to Immunotherapy. Trends in cancer. 6(5). 432–441. 95 indexed citations
5.
Fousek, Kristen, Lucas A. Horn, & Claudia Palena. (2020). Interleukin-8: A chemokine at the intersection of cancer plasticity, angiogenesis, and immune suppression. Pharmacology & Therapeutics. 219. 107692–107692. 230 indexed citations
6.
Morillon, Y. Maurice, Claire Smalley, Samuel T. Pellom, et al.. (2020). The Use of a Humanized NSG-β2m−/− Model for Investigation of Immune and Anti-tumor Effects Mediated by the Bifunctional Immunotherapeutic Bintrafusp Alfa. Frontiers in Oncology. 10. 549–549. 18 indexed citations
7.
Greene, Sarah, Yvette Robbins, Wojciech K. Mydlarz, et al.. (2019). Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models. Clinical Cancer Research. 26(6). 1420–1431. 217 indexed citations
8.
Ostrand‐Rosenberg, Suzanne, Daniel W. Beury, Katherine H. Parker, & Lucas A. Horn. (2019). Survival of the fittest: how myeloid-derived suppressor cells survive in the inhospitable tumor microenvironment. Cancer Immunology Immunotherapy. 69(2). 215–221. 52 indexed citations
9.
Ostrand‐Rosenberg, Suzanne, et al.. (2019). Radiotherapy Both Promotes and Inhibits Myeloid-Derived Suppressor Cell Function: Novel Strategies for Preventing the Tumor-Protective Effects of Radiotherapy. Frontiers in Oncology. 9. 215–215. 57 indexed citations
10.
Sun, Lillian, Paúl E. Clavijo, Yvette Robbins, et al.. (2019). Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy. JCI Insight. 4(7). 188 indexed citations
11.
Horn, Lucas A., et al.. (2017). Soluble CD80 Protein Delays Tumor Growth and Promotes Tumor-Infiltrating Lymphocytes. Cancer Immunology Research. 6(1). 59–68. 28 indexed citations
12.
Mutton, Laura N., Ryan P. McMullin, Jessica Hicks, et al.. (2015). Combined MYC Activation and Pten Loss Are Sufficient to Create Genomic Instability and Lethal Metastatic Prostate Cancer. Cancer Research. 76(2). 283–292. 93 indexed citations
13.
Ostrand‐Rosenberg, Suzanne, et al.. (2015). Novel strategies for inhibiting PD-1 pathway-mediated immune suppression while simultaneously delivering activating signals to tumor-reactive T cells. Cancer Immunology Immunotherapy. 64(10). 1287–1293. 19 indexed citations
14.
Haile, Samuel, Lucas A. Horn, & Suzanne Ostrand‐Rosenberg. (2014). A Soluble Form of CD80 Enhances Antitumor Immunity by Neutralizing Programmed Death Ligand-1 and Simultaneously Providing Costimulation. Cancer Immunology Research. 2(7). 610–615. 36 indexed citations
15.
Parker, Katherine H., Pratima Sinha, Lucas A. Horn, et al.. (2014). HMGB1 Enhances Immune Suppression by Facilitating the Differentiation and Suppressive Activity of Myeloid-Derived Suppressor Cells. Cancer Research. 74(20). 5723–5733. 208 indexed citations
16.
Horn, Lucas A., Jeff Leips, & Michelle Starz‐Gaiano. (2014). Phagocytic ability declines with age in adult Drosophila hemocytes. Aging Cell. 13(4). 719–728. 49 indexed citations
17.
Ostrand‐Rosenberg, Suzanne, Lucas A. Horn, & Samuel Haile. (2014). The Programmed Death-1 Immune-Suppressive Pathway: Barrier to Antitumor Immunity. The Journal of Immunology. 193(8). 3835–3841. 181 indexed citations
18.
Sinha, Pratima, Katherine H. Parker, Lucas A. Horn, & Suzanne Ostrand‐Rosenberg. (2012). Tumor‐induced myeloid‐derived suppressor cell function is independent of IFN‐γ and IL‐4Rα. European Journal of Immunology. 42(8). 2052–2059. 57 indexed citations
19.
Horn, Lucas A., et al.. (2010). Age- and Diet-Specific Effects of Variation at S6 Kinase on Life History, Metabolic, and Immune Response Traits in Drosophila melanogaster. DNA and Cell Biology. 29(9). 473–485. 11 indexed citations
20.
Horn, Lucas A., et al.. (1996). The anti-haemostatic strategies of the human hookwormNecator americanus. Parasitology. 112(1). 81–87. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomasz Ahrends Breakdown of academic impact, for papers by Kim Vrijland Breakdown of academic impact, for papers by Armelle Prévost‐Blondel Breakdown of academic impact, for papers by Elisa Peranzoni Breakdown of academic impact, for papers by Elise Alspach Breakdown of academic impact, for papers by Eva Van Overmeire Breakdown of academic impact, for papers by Helena Harlin Breakdown of academic impact, for papers by Alessandra Mancino Breakdown of academic impact, for papers by Beom K. Choi Breakdown of academic impact, for papers by Tomohisa Baba
Rankless by CCL
2026